Approximately 5.1 million persons in the United States have clinically manifest HF, and the Table 2. Associated Guidelines and Statements Title Organization Publication Year (Reference) Guidelines Guidelines for the Management of Adults With Congenital Heart Disease ACCF/AHA 2008 (6) Guidelines for the Management of Patients With Atrial Fibrillation ACCF/AHA/HRS 2011 (7 9) Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults ACCF/AHA 2010 (10) Guideline for Coronary Artery Bypass Graft Surgery ACCF/AHA 2011 (11) Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities ACCF/AHA/HRS 2013 (5) Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy ACCF/AHA 2011 (12) Guideline for Percutaneous Coronary Intervention ACCF/AHA/SCAI 2011 (13) Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease Guideline for the Management of ST-Elevation Myocardial Infarction ACCF/AHA 2013 (16) Guidelines for the Management of Patients With Unstable Angina/ Non ST-Elevation Myocardial Infarction Guidelines for the Management of Patients With Valvular Heart Disease ACCF/AHA 2008 (18) Comprehensive Heart Failure Practice Guideline HFSA 2010 (19) Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure ESC 2012 (20) Chronic Heart Failure: Management of Chronic Heart Failure in Adults in Primary and Secondary Care Antithrombotic Therapy and Prevention of Thrombosis ACCP 2012 (22) Guidelines for the Care of Heart Transplant Recipients ISHLT 2010 (23) Statements Contemporary Definitions and Classification of the Cardiomyopathies AHA 2006 (24) Genetics and Cardiovascular Disease AHA 2012 (25) Appropriate Utilization of Cardiovascular Imaging in Heart Failure ACCF 2013 (26) Appropriate Use Criteria for Coronary Revascularization Focused Update ACCF 2012 (27) Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond Decision Making in Advanced Heart Failure AHA 2012 (31) Recommendations for the Use of Mechanical Circulatory Support: Device Strategies and Patient Selection Advanced Chronic Heart Failure ESC 2007 (33) Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation Third Universal Definition of Myocardial Infarction ESC/ACCF/AHA/WHF 2012 (35) AACVPR indicates American Association of Cardiovascular and Pulmonary Rehabilitation; AATS, American Association for Thoracic Surgery; ACCF, American College of Cardiology Foundation; ACCP, American College of Chest Physicians; ACP, American College of Physicians; AHA, American Heart Association; ASA, American Stroke Association; ESC, European Society of Cardiology; HFSA, Heart Failure Society of America; HRS, Heart Rhythm Society; ISHLT, International Society for Heart and Lung Transplantation; NHLBI, National Heart, Lung, and Blood Institute; NICE, National Institute for Health and Clinical Excellence; PCNA, Preventive Cardiovascular Nurses Association; SCAI, Society for Cardiovascular Angiography and Interventions; STS, Society of Thoracic Surgeons; and WHF, World Heart Federation. 